In addition, immunocytochemical analysis of these markers (p-S6/S6 and p-mTOR/mTOR) further confirmed the enhanced activation of the mTOR pathway in MDS iPSC-derived neurons (Figures S1E–S1H). This evidence concerns the gene MTOR and myelodysplastic syndrome.